Abnormality of the Middle Phalanx of the 4Th Toe Abnormality of The
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Te2, Part Iii
TERMINOLOGIA EMBRYOLOGICA Second Edition International Embryological Terminology FIPAT The Federative International Programme for Anatomical Terminology A programme of the International Federation of Associations of Anatomists (IFAA) TE2, PART III Contents Caput V: Organogenesis Chapter 5: Organogenesis (continued) Systema respiratorium Respiratory system Systema urinarium Urinary system Systemata genitalia Genital systems Coeloma Coelom Glandulae endocrinae Endocrine glands Systema cardiovasculare Cardiovascular system Systema lymphoideum Lymphoid system Bibliographic Reference Citation: FIPAT. Terminologia Embryologica. 2nd ed. FIPAT.library.dal.ca. Federative International Programme for Anatomical Terminology, February 2017 Published pending approval by the General Assembly at the next Congress of IFAA (2019) Creative Commons License: The publication of Terminologia Embryologica is under a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license The individual terms in this terminology are within the public domain. Statements about terms being part of this international standard terminology should use the above bibliographic reference to cite this terminology. The unaltered PDF files of this terminology may be freely copied and distributed by users. IFAA member societies are authorized to publish translations of this terminology. Authors of other works that might be considered derivative should write to the Chair of FIPAT for permission to publish a derivative work. Caput V: ORGANOGENESIS Chapter 5: ORGANOGENESIS -
California Tumor Tissue Registry Eighty-Eighth Semi
CALIFORN IA TUMOR TISSUE REGISTRY EIGHTY-EIGHTH SEMI -ANNUAL SLIDE SEMINAR ON TUMORS OF THE CENTRAL NERVOUS SYSTEM MODERATOR: BERN W. SCHti THAUER, M. D. HEAD SECTION OF SURGICAL PATHOLOGY MAYO CLINIC PROFESSOR OF PATHOLOGY ROCHESTER, MINNESOTA CHAIRMAN: PHILIP VAN HALE, M. D. ASSOCIATE PATHOLOGIST HUNTINGTON MEMORIAL HOSP ITAL PASADENA, CALIFORNIA SUNDAY - JUNE 3, 1990 9:00 A.M. - 5:00 P.M. REGISTRATION: 7:30 A.M. SHERATON PLAZA LA REINA ~OTEL LOS ANGELES, CALIFORNIA (213) 642-1111 Please bring your protocol, but do not bring slides or microscopes to the meeting. CONTRIBUTOR: Bernd W. Scheithauer, M. 0. JUNE 1990 - CASE NO. 1 Rochester, Minnesota TISSUE FROM: Brain, left temporal parietal lobe ACCESSION NO. 26731 CLINICAL ABSTRACT : The patient is a 46 -year-old white ma le wh o experienced a head injury in 1960 but had no history of neurologic disturbances until 1982 at which time he noted the sudden onset of expressive aphasia. CT scan demonstrated a hypodense left temporoparietal lesion associated with a cyst. No enhancement was seen. - The patient elected to be medically observed over a five year interval, there being no intervention until symptoms interfered with his lifestyle. During that time he was maintained on phenobabital. The frequen cy of his partial complex seizures, which were characterized by expressive more than receptive aphasia, varied from one per month to six per week. They lasted from 1 to 30 minutes. No sensorimotor component was ever observed. Memory deficits followed the episodes. The first evidence of tumor enhancement was noted in 1984 and was seen to be somewhat more extensive in a 1986 study. -
TAHUN 2018 [Kos Perkhidmat an (RM)] PEMBEDAHAN AM 1 Pharyngo
JADUAL 6 FI PEMBEDAHAN TAHUN TAHUN TAHUN TAHUN 2018 [Kos Bil. Prosedur (BM) 2016 2015 (RM) 2017 (RM) Perkhidmat (RM) an (RM)] PEMBEDAHAN AM 1 Pharyngo-laryngo-oesophagectomy with reconstruction 5,407 7,012 8,617 11,024 2 Tracheo-oesophageal fistula 4,673 5,789 6,904 8,578 3 Total pancreatectomy 4,451 5,419 6,386 7,837 4 Pancreato duodenectomy (eg.Whipple’s operation) 4,451 5,419 6,386 7,837 5 Adrenalectomy 3,924 4,540 5,156 6,080 6 Adrenalectomy – bilateral 4,052 4,753 5,454 6,505 7 Total Parotidectomy –preserving of facial nerve 2,729 3,548 4,367 5,595 8 Partial Parotidectomy –preserving of facial nerve 2,517 3,195 3,873 4,890 9 Total thyroidectomy 2,252 2,753 3,254 4,005 10 Partial thyroidectomy 2,211 2,685 3,159 3,870 11 Hemithyroidectomy 2,211 2,685 3,159 3,870 12 Subtotal thyroidectomy bilateral 2,234 2,723 3,212 3,945 13 Thyroglossal Cyst 1,694 1,824 1,953 2,147 14 Block Dissection of cervical glands 3,170 4,284 5,397 7,068 15 Parathyroidectomy 2,410 3,017 3,623 4,533 16 Mastectomy with/without axillary clearance 1,935 2,226 2,516 2,951 17 Wide excision for carcinoma breast 1,760 1,934 2,107 2,367 18 Total oesophagectomy and interposition of intestine 4,532 6,554 8,575 11,607 19 Repair of diaphragmatic hernia-transabdominal 2,322 2,870 3,418 4,240 20 Total gastrectomy 2,635 3,392 4,149 5,284 21 Partial gastrectomy (benign disease) 2,274 2,790 3,305 4,079 22 Partial gastrectomy (malignant disease) 2,451 3,085 3,718 4,669 Page 1 JADUAL 6 FI PEMBEDAHAN TAHUN TAHUN TAHUN TAHUN 2018 [Kos Bil. -
Hypothyroidism Mauricio Alvarez Andrade and Oscar Rosero Olarte
Chapter Hypothyroidism Mauricio Alvarez Andrade and Oscar Rosero Olarte Abstract Hypothyroidism is a condition that results from thyroid hormone deficiency that can range from an asymptomatic condition to a life-threatening disease. The prevalence of hypothyroidism varies according to the population, from up to 3 to 4% in some populations and in the case of subclinical hypothyroidism up to 5–10%. Clinical symptoms of hypothyroidism are diverse, broad, and non-specific and can be related to many systems, reflecting the systemic effects of thyroid hormones. The severity of the symptoms is usually related to the severity of the thyroid hor- mone deficit. The most common form of hypothyroidism, primary hypothyroid- ism, is diagnosed when there is elevation of TSH and decrease in the level of free T4 and Subclinical hypothyroidism is diagnosed when there is an elevation of TSH with normal levels of free T4. The most frequent cause of primary hypothyroid- ism in populations without iodine deficiency is Hashimoto’s thyroiditis or chronic lymphocytic thyroiditis. Iodine deficiency is the main cause of hypothyroidism in populations with deficiency of iodine intake. The treatment of choice for hypothy- roidism is thyroxine (T4), which has shown efficacy in multiple studies to restore the euthyroid state and improve the symptoms of hypothyroidism. In subclinical hypothyroidism, the treatment depends on the age, functionality, and comorbidi- ties of the patients. The total replacement dose of levothyroxine in adults is approxi- mately 1.6 mcg/kg; however in elderly patients with heart disease or coronary heart disease, the starting dose should be from 0.3 to 0.4 mcg/kg/day with progressive increase of 10% of the dose monthly. -
Vesicovaginal Fistula (Vvf) 1
VESICOVAGINAL FISTULA (VVF) 1 REVIEW PROF-1186 VESICOVAGINAL FISTULA (VVF) PROF. DR. M. SHUJA TAHIR PROF. DR. MAHNAZ ROOHI FRCS (Edin), FCPS Pak (Hon) FRCOG (UK) Professor of Surgery Professor & Head of Department Gynae & Obst. Independent Medical College, Gynae Unit-I, Allied Hospital, Faisalabad. Punjab Medical College, Faisalabad. Article Citation: Muhammad Shuja Tahir, Mahnaz Roohi. Vesicovaginal fistula (VVF). Professional Med J Mar 2009; 16(1): 1-11. ABSTRACT... Vesicovaginal fistula is not an uncommon condition. It gives rise to multiple socio-psychological problems for women usually of younger age. It can be prevented by improving the level of education, health care and poverty. Early diagnosis and appropriate treatment is required to help the patient. Preoperative assessment , treatment of co-morbid factors, proper surgical approach & technique ensures success of surgery. Postoperative care of the patient is equally important to avoid surgical failure. addition to the medical sequelae from these fistulas. It can be caused by injury to the urinary tract, which can occur accidentally during surgery to the pelvic area, such as a hysterectomy. It can also be caused by a tumor in the vesicovaginal area or by reduced blood supply due to tissue death (necrosis) caused by radiation therapy or prolonged labor during childbirth. Patients with vaginal fistulas usually present 1 to 3 weeks after a gynecologic surgery with complaints of continuous urinary incontinence, vaginal discharge, pain or an abnormal urinary stream. Obstetric fistula lies along a continuum of problems affecting women's reproductive health, starting with genital infections and finishing with Vesicovaginal fistula maternal mortality. It is the single most dramatic aftermath of neglected childbirth due to its disabling It is a condition that arises mostly from trauma sustained nature and dire social, physical and psychological during child birth or pelvic operations caused by the consequences. -
Hipotiroidismo Congénito Central: Correlaciones Clínico-Genéticas E Investigación De Sus Mecanismos Moleculares
Universidad Autónoma de Madrid. Departamento de Bioquímica. Hipotiroidismo congénito central: correlaciones clínico-genéticas e investigación de sus mecanismos moleculares Marta García González Madrid, 2017 Departamento de Bioquímica. Facultad de Medicina. Universidad Autónoma de Madrid. Hipotiroidismo congénito central: correlaciones clínico-genéticas e investigación de sus mecanismos moleculares Doctoranda: Marta GARCÍA GONZÁLEZ. Licenciada en Ciencias Biológicas. Universidad Complutense de Madrid. Director: Dr. José Carlos Moreno Navarro. Laboratorio Molecular de Tiroides. Instituto de Genética Médica y Molecular (INGEMM). Hospital Universitario La Paz (Madrid). José Carlos Moreno Navarro, Doctor en Medicina y Director del Laboratorio Molecular de Tiroides en el Instituto de Genética Médica y Molecular (INGEMM) del Hospital Universitario La Paz, Madrid. CERTIFICA: Que Marta García González, Licenciada en Biología y Máster en Bioquímica, Biología Molecular y Biomedicina por la Universidad Complutense de Madrid, ha realizado bajo su dirección el trabajo de investigación titulado: Hipotiroidismo congénito central: correlaciones clínico-genéticas e investigación de sus mecanismos moleculares El que suscribe considera el trabajo realizado satisfactorio y apto para ser presentado como Tesis Doctoral en el Departamento de Bioquímica de la Facultad de Medicina de la Universidad Autónoma de Madrid. Y para que conste donde proceda expiden el presente certificado en Madrid a 19 de Junio de 2017. Fdo. José Carlos Moreno Navarro Marta García González. -
Enteric Peripheral Neuroblastoma in a Calf
NOTE Pathology Enteric peripheral neuroblastoma in a calf Yusuke SAKAI1)*, Masato HIYAMA2), Saya KAGIMOTO1), Yuki MITSUI1, Miko IMAIUMI1), Takeshi OKAYAMA3), Kaori HARADONO3), Masashi SAKURAI1) and Masahiro MORIMOTO1) 1)Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi-shi, Yamaguchi 753-8515, Japan 2)Laboratory of Large Animal Clinical Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi-shi, Yamaguchi 753-8515, Japan 3)Tobu Large Animal Clinic, NOSAI Yamaguchi, 512-2 Kuhara, Shuto-cho, Iwakuni-shi, Yamaguchi 742-0417, Japan ABSTRACT. An 11-month-old female Japanese Black calf had showed chronic intestinal J. Vet. Med. Sci. symptoms. A large mass surrounding the colon wall that was continuous with the colon 81(6): 824–827, 2019 submucosa was surgically removed. After recurrence and euthanasia, a large mass in the colon region and metastatic masses in the omentum, liver, and lung were revealed at necropsy. doi: 10.1292/jvms.18-0450 Pleomorphic small cells proliferated in the mass and muscular layer of the colon. The cells were positively stained with anti-doublecortin (DCX), PGP9.5, nestin, and neuron specific enolase (NSE). Thus, the diagnosis of peripheral neuroblastoma was made. This is the first report of enteric Received: 31 July 2018 peripheral neuroblastoma in animals. Also, clear DCX staining signal suggested usefulness of DCX Accepted: 31 March 2019 immunohistochemistry to differentiate the neuroblastoma from other small cell tumors in cattle. Published online in J-STAGE: cattle, doublecortin, neuronal marker, neuronal neoplasm, peripheral neuroblastoma 9 April 2019 KEY WORDS: Neuroblastoma is an embryonal neuroectodermal neoplasm with limited neuronal differentiation that arises both in the central and peripheral nervous systems [12]. -
A Molecular Target for Human Glioblastoma
Kuan et al. BMC Cancer 2010, 10:468 http://www.biomedcentral.com/1471-2407/10/468 RESEARCH ARTICLE Open Access MRP3: a molecular target for human glioblastoma multiforme immunotherapy Chien-Tsun Kuan1,2*†, Kenji Wakiya1,2†, James E Herndon II2, Eric S Lipp2, Charles N Pegram1,2, Gregory J Riggins3, Ahmed Rasheed1, Scott E Szafranski1, Roger E McLendon1,2, Carol J Wikstrand4, Darell D Bigner1,2* Abstract Background: Glioblastoma multiforme (GBM) is refractory to conventional therapies. To overcome the problem of heterogeneity, more brain tumor markers are required for prognosis and targeted therapy. We have identified and validated a promising molecular therapeutic target that is expressed by GBM: human multidrug-resistance protein 3 (MRP3). Methods: We investigated MRP3 by genetic and immunohistochemical (IHC) analysis of human gliomas to determine the incidence, distribution, and localization of MRP3 antigens in GBM and their potential correlation with survival. To determine MRP3 mRNA transcript and protein expression levels, we performed quantitative RT-PCR, raising MRP3-specific antibodies, and IHC analysis with biopsies of newly diagnosed GBM patients. We used univariate and multivariate analyses to assess the correlation of RNA expression and IHC of MRP3 with patient survival, with and without adjustment for age, extent of resection, and KPS. Results: Real-time PCR results from 67 GBM biopsies indicated that 59/67 (88%) samples highly expressed MRP3 mRNA transcripts, in contrast with minimal expression in normal brain samples. Rabbit polyvalent and murine monoclonal antibodies generated against an extracellular span of MRP3 protein demonstrated reactivity with defined MRP3-expressing cell lines and GBM patient biopsies by Western blotting and FACS analyses, the latter establishing cell surface MRP3 protein expression. -
Nomina Histologica Veterinaria, First Edition
NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria. -
Nomenclatore Per L'anatomia Patologica Italiana Arrigo Bondi
NAP Nomenclatore per l’Anatomia Patologica Italiana Versione 1.9 Arrigo Bondi Bologna, 2016 NAP v. 1.9, pag 2 Arrigo Bondi * NAP - Nomenclatore per l’Anatomia Patologica Italiana Versione 1.9 * Componente Direttivo Nazionale SIAPEC-IAP Società Italiana di Anatomia Patologica e Citodiagnostica International Academy of Pathology, Italian Division NAP – Depositato presso S.I.A.E. Registrazione n. 2012001925 Distribuito da Palermo, 1 Marzo 2016 NAP v. 1.9, pag 3 Sommario Le novità della versione 1.9 ............................................................................................................... 4 Cosa è cambiato rispetto alla versione 1.8 ........................................................................................... 4 I Nomenclatori della Medicina. ........................................................................................................ 5 ICD, SNOMED ed altri sistemi per la codifica delle diagnosi. ........................................................... 5 Codifica medica ........................................................................................................................... 5 Storia della codifica in medicina .................................................................................................. 5 Lo SNOMED ............................................................................................................................... 6 Un Nomenclatore per l’Anatomia Patologica Italiana ................................................................. 6 Il NAP ................................................................................................................................................. -
Sinonasal Tumors
Prepared by Kurt Schaberg Sinonasal/Nasopharyngeal Tumors Benign Sinonasal Papillomas aka Schneiderian papilloma Morphology Location Risk of Molecular transformation Exophytic Exophytic growth; Nasal Very low risk Low-risk HPV immature squamous epithelium septum subtypes Inverted Inverted ‘‘ribbonlike’’ growth; Lateral Low to EGFR immature squamous epithelium; wall and Intermediate risk mutations or transmigrating intraepithelial sinuses low-risk HPV neutrophilic inflammation subtypes Oncocytic Exophytic and endophytic growth; Lateral Low to KRAS multilayered oncocytic epithelium; wall and intermediate microcysts and intraepithelial sinuses neutrophilic microabscesses Modified from: Weindorf et al. Arch Pathol Lab Med—Vol 143, November 2019 Oncocytic Sinonasal Papilloma Note the abundant oncocytic epithelium with numerous neutrophils Inverted Sinonasal Papilloma Note the inverted, “ribbon-like” growth Respiratory Epithelial Adenomatoid Hamartoma aka “REAH” Sinonasal glandular proliferation arising from the surface epithelium (i.e., in continuity with the surface). Invaginations of small to medium-sized glands surrounded by hyalinized stroma with characteristic thickened, eosinophilic basement membrane Exists on a spectrum with seromucinous hamartoma, which has smaller glands. Should be able to draw a circle around all of the glands though, if too confluent → consider a low-grade adenocarcinoma Inflammatory Polyp Surface ciliated, sinonasal mucosa, possibly with squamous metaplasia. Edematous stroma (without a proliferation of seromucinous glands). Mixed inflammation (usu. Lymphocytes, plasma cells, and eosinophils) Pituitary adenoma Benign anterior pituitary tumor Although usually primary to sphenoid bone, can erode into nasopharynx or be ectopic Can result in endocrine disorders, such as Cushing’s disease or acromegaly. Solid, nested, or trabecular growth of epithelioid cells with round nuclei and speckled chromatin and eosinophilic, granular chromatin. Express CK, and neuroendocrine markers. -
BGD B Lecture Notes Docx
BGD B Lecture notes Lecture 1: GIT Development Mark Hill Trilaminar contributions • Overview: o A simple tube is converted into a complex muscular, glandular and duct network that is associated with many organs • Contributions: o Endoderm – epithelium of the tract, glands, organs such as the liver/pancreas/lungs o Mesoderm (splanchnic) – muscular wall, connective tissue o Ectoderm (neural crest – muscular wall neural plexus Gastrulation • Process of cell migration from the epiblast through the primitive streak o Primitive streak forms on the bilaminar disk o Primitive streak contains the primitive groove, the primitive pit and the primitive node o Primitive streak defines the body axis, the rostral caudal ends, and left and right sides Thus forms the trilaminar embryo – ectoderm, mesoderm, endoderm • Germ cell layers: o ectoderm – forms the nervous system and the epidermis epithelia 2 main parts • midline neural plate – columnar epithelium • lateral surface ectoderm – cuboidal, containing sensory placodes and skin/hair/glands/enamel/anterior pituitary epidermis o mesoderm – forms the muscle, skeleton, and connective tissue cells migrate second migrate laterally, caudally, rostrally until week 4 o endoderm – forms the gastrointestinal tract epithelia, the respiratory tract and the endocrine system cells migrate first and overtake the hypoblast layer line the primary yolk sac to form the secondary yolk sac • Membranes: o Rostrocaudal axis Ectoderm and endoderm form ends of the gut tube, no mesoderm At each end, form the buccopharyngeal